Cellectar Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Cellectar Biosciences, Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 15.28% of the total amount of its stocks outstanding. This makes up a total of 1.07M shares of Cellectar Biosciences, Inc.. Compared to the previous quarter, the number fell by -42.70% or -803.22K shares fewer. As for the holding position changes, 25% (3) of current hedge fund investors increased the number of shares held, 8.33% (1) of current holders sold a part of the shares held, and 25% (3) closed the holdings completely. 1 hedge funds are new holders of Cellectar Biosciences, Inc. stock in Q1 2023, it is 8.33% of total holders.
Hedge funds holding Cellectar Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 14 |
|---|---|
| Q3 2018 | 13 |
| Q4 2018 | 11 |
| Q1 2019 | 10 |
| Q2 2019 | 12 |
| Q3 2019 | 11 |
| Q4 2019 | 9 |
| Q1 2020 | 15 |
| Q2 2020 | 22 |
| Q3 2020 | 19 |
| Q4 2020 | 38 |
| Q1 2021 | 43 |
| Q2 2021 | 42 |
| Q3 2021 | 36 |
| Q4 2021 | 36 |
| Q1 2022 | 29 |
| Q2 2022 | 30 |
| Q3 2022 | 19 |
| Q4 2022 | 24 |
| Q1 2023 | 12 |
Hedge funds changes in Cellectar Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 3 | 2 | 1 | 2 | 6 |
|---|---|---|---|---|---|
| Q3 2018 | 11 | 1 | 0 | 12 | -11 |
| Q4 2018 | 2 | 2 | 1 | 4 | 2 |
| Q1 2019 | 0 | 1 | 2 | 1 | 6 |
| Q2 2019 | 3 | 2 | 1 | 1 | 5 |
| Q3 2019 | 3 | 2 | 2 | 4 | 0 |
| Q4 2019 | 2 | 1 | 2 | 4 | 0 |
| Q1 2020 | 7 | 1 | 1 | 0 | 6 |
| Q2 2020 | 11 | 3 | 2 | 4 | 2 |
| Q3 2020 | 3 | 5 | 5 | 6 | 0 |
| Q4 2020 | 26 | 4 | 2 | 6 | 0 |
| Q1 2021 | 16 | 12 | 6 | 11 | -2 |
| Q2 2021 | 9 | 17 | 6 | 10 | 0 |
| Q3 2021 | 8 | 9 | 5 | 13 | 1 |
| Q4 2021 | 8 | 7 | 6 | 8 | 7 |
| Q1 2022 | 2 | 5 | 4 | 9 | 9 |
| Q2 2022 | 5 | 5 | 5 | 4 | 11 |
| Q3 2022 | 18 | 1 | 0 | 29 | -29 |
| Q4 2022 | 8 | 7 | 1 | 2 | 6 |
| Q1 2023 | 1 | 3 | 1 | 3 | 4 |